Rivaroxaban monotherapy noninferior in atrial fibrillation and stable coronary disease
Rivaroxaban monotherapy is noninferior to combination therapy in patients with atrial fibrillation and stable coronary artery disease either not requiring intervention or more than one year after revascularisation….
Long-Term Use of Aspirin Doesn’t Lower Risk of Stroke in Some Patients with Atrial Fibrillation
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found that using long-term aspirin therapy to prevent strokes among patients who…